Inefficiency of cisplatin plus 5-FU as second-or third line treatment in advanced breast cancer

Ann Oncol. 1991 Jul;2(7):521. doi: 10.1093/oxfordjournals.annonc.a058008.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Cisplatin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Middle Aged
  • Remission Induction

Substances

  • Cisplatin
  • Fluorouracil